PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca2+/Calmodulin-Dependent kinase II-δ activation in mouse models of down syndrome

Journal of Comparative Neurology

Volumn 519, Issue 14, 2011, Pages 2779-2802

  Mouton Liger, François ^a   Thomas, Sophie ^a   Rattenbach, Revital ^a   Magnol, Laetitia ^b   Larigaldie, Vanessa ^b   Ledru, Aurelie ^a   Herault, Yann ^b   Verney, Catherine ^c   Créau, Nicole ^a  

^a Groupe Hospitalier Pitié Salpêtrière   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INSERM   (France)

Author keywords

CaMKII; Neuronal differentiation; Pcp4 Pep19; TgPCP4; Ts1Cje

Indexed keywords

BETA III TUBULIN; BETA TUBULIN; CALBINDIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA; CALRETININ; GENE PRODUCT; MICROTUBULE ASSOCIATED PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN 2 C; PEP19 PROTEIN; PURKINJE CELL PROTEIN 4; UNCLASSIFIED DRUG;

ABDUCENS NERVE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; BRAIN; BRAIN DEVELOPMENT; CELL LABELING; CONTROLLED STUDY; CRANIAL GANGLION; CRANIAL NERVE; DIENCEPHALON; DISEASE MODEL; DOWN SYNDROME; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; GANGLION; GENE; GENE OVEREXPRESSION; GLOSSOPHARYNGEAL NERVE; HYBRIDIZATION; HYPOTHALAMUS; IMMUNOFLUORESCENCE TEST; INTERMEDIATE RETICULAR NUCLEUS; INTRACELLULAR SIGNALING; MESENCEPHALON; MITOSIS; MOUSE; MYELENCEPHALON; NERVE CELL DIFFERENTIATION; NERVE FIBER; NONHUMAN; NUCLEOTIDE SEQUENCE; PEP19 GENE; PRIMORDIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PURKINJE CELL; PURKINJE CELL PROTEIN 4 GENE; RHOMBENCEPHALON; SOLITARY TRACT NUCLEUS; SPINAL GANGLION; SUPERIOR COLLICULUS; TELENCEPHALON; THALAMUS; TOTO HYBRIDIZATION; TRANSGENIC MOUSE; TRIGEMINUS GANGLION; VAGUS NERVE; VESTIBULOCOCHLEAR NERVE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL DIFFERENTIATION; DOWN SYNDROME; EMBRYO, MAMMALIAN; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; SIGNAL TRANSDUCTION;

EID: 79960863772     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.22651     Document Type: Article

References (93)

1. Aldridge K, Reeves RH, Olson LE, Richtsmeier JT. 2007. Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. Am J Med Genet A 143A: 1060-1070.
2. Altman J, Bayer SA. 1985. Embryonic development of the rat cerebellum. II. Translocation and regional distribution of the deep neurons. J Comp Neurol 231: 27-41.
3. Amano K, Sago H, Uchikawa C, Suzuki T, Kotliarova SE, Nukina N, Epstein CJ, Yamakawa K. 2004. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Hum Mol Genet 13: 1333-1340.
4. Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, Macklis JD. 2005. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45: 207-221.
5. Bastianelli E. 2003. Distribution of calcium-binding proteins in the cerebellum. [Review] Cerebellum. 2: 242-262.
6. Bayer KU, Löhler J, Schulman H, Harbers K. 1999. Developmental expression of the CaM kinase II isoforms: ubiquitous gamma- and delta-CaM kinase II are the early isoforms and most abundant in the developing nervous system. Brain Res Mol Brain Res 70: 147-154.
7. Becker LE, Armstrong DL, Chan F. 1986. Dendritic atrophy in children with Down's syndrome. Ann Neurol 20: 520-526.
8. Becker L, Mito T, Takashima S, Onodera K. 1991. Growth and development of the brain in Down syndrome. Prog Clin Biol Res 373: 133-152.
9. Belichenko PV, Kleschevnikov AM, Salehi A, Epstein CJ, Mobley WC. 2007. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. J Comp Neurol 504: 329-345.
10. Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC. 2009. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci 29: 5938-5948.
11. Belo JA, Bouwmeester T, Leyns L, Kertesz N, Gallo M, Follettie M, De Robertis EM. 1997. Cerberus-like is a secreted factor with neutralizing activity expressed in the anterior primitive endoderm of the mouse gastrula. Mech Dev 68: 45-45.
12. Besson V, Brault V, Duchon A, Togbe D, Bizot JC, Quesniaux VF, Ryffel B, Hérault Y. 2007. Modeling the monosomy for the telomeric part of human chromosome 21 reveals haploinsufficient genes modulating the inflammatory and airway responses. Hum Mol Genet 16: 2040-2052.
13. Blaas HG, Eik-Nes SH, Kiserud T, Hellevik LR. 1995. Early development of the hindbrain: a longitudinal ultrasound study from 7 to 12 weeks of gestation. Ultrasound Obstet Gynecol 5: 151-160.
14. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
15. Bulfone A, Caccioppoli C, Pardini C, Faedo A, Martinez S, Banfi S. 2004. Pcp4l1, a novel gene encoding a Pcp4-like polypeptide, is expressed in specific domains of the developing brain. Gene Expr Patterns 4: 297-301.
16. 2+/calmodulin-dependent protein kinase in developing rat brain. J Neurosci 10: 1788-1798.
17. Buxhoeveden D, Casanova MF. 2003. Accelerated maturation in brains of patients with Down syndrome. J Intellect Disabil Res 48: 705-706.
18. Buxhoeveden D, Fobbs A, Roy E, Casanova M. 2002. Quantitative comparison of radial cell columns in children with Down's syndrome and controls. J Intellect Disabil Res 46: 76-81.
19. Cabin DE, Gardiner K, Reeves RH. 1996. Molecular genetic characterization and comparative mapping of the human PCP4 gene. Somat Cell Mol Genet 22: 167-175.
20. Caran N, Johnson LD, Jenkins KJ, Tombes RM. 2001. Cytosolic targeting domains of gamma and delta calmodulin-dependent protein kinase II. J Biol Chem 276: 42514-42519.
21. Choi WS, Chun SY, Markelonis GJ, Oh TH, Oh YJ. 2001. Overexpression of calbindin-D28K induces neurite outgrowth in dopaminergic neuronal cells via activation of p38 MAPK. Biochem Biophys Res Commun 287: 656-656.
22. Clancy B, Darlington RB, Finlay BL. 2001. Translating developmental time across mammalian species. Neuroscience 105: 7-17.
23. Conlon RA, Rossant J. 1992. Exogenous retinoic acid rapidly induces anterior ectopic expression of murine Hox-2 genes in vivo. Development 116: 357-368.
24. Coskun V, Luskin MB. 2001. The expression pattern of the cell cycle inhibitor p19(INK4d) by progenitor cells of the rat embryonic telencephalon and neonatal anterior subventricular zone. J Neurosci 21: 3092-3103.
25. Crété N, Delabar JM, Sinet PM, Créau-Goldberg N. 1991. Accurate evaluation of the sizes of DNA fragments (from 30 to 4700 kb) in pulse field gel electrophoresis. Biotechniques 11: 711-712, 714, 716.
26. Crome I, Cowie, Slater E. 1966. A statistical note on cerebellar and brain-stem weight in mongolism. J Ment Def Res 10: 69-77.
27. Dehmelt L, Smart FM, Ozer RS, Halpain S. 2003. The role of microtubule-associated protein 2c in the reorganization of microtubules and lamellipodia during neurite initiation. J Neurosci 23: 9479-9490.
28. Dehmelt L, Nalbant P, Steffen W, Halpain SA. 2006. A microtubule-based, dynein-dependent force induces local cell protrusions: implications for neurite initiation. Brain Cell Biol 35: 39-56.
29. Diño MR, Willard FH, Mugnaini E. 1999. Distribution of unipolar brush cells and other calretinin immunoreactive components in the mammalian cerebellar cortex. J Neurocytol 28: 99-123.
30. Easter SS Jr, Ross LS, Frankfurter A. 1993. Initial tract formation in the mouse brain. J Neurosci 13: 285-299.
31. Erhardt JA, Legos JJ, Johanson RA, Slemmon JR, Wang X. 2000. Expression of PEP-19 inhibits apoptosis in PC12 cells. Neuroreport 11: 3719-3723.
32. 2+/calmodulin-dependent protein kinase in rat brain. J Neurosci 5: 3270-3277.
33. Fink AJ, Englund C, Daza RA, Pham D, Lau C, Nivison M, Kowalczyk T, Hevner RF. 2006. Development of the deep cerebellar nuclei: transcription factors and cell migration from the rhombic lip. J Neurosci 26: 3066-3076.
34. Francis F, Koulakoff A, Boucher D, Chafey P, Schaar B, Vinet MC, Friocourt G, McDonnell N, Reiner O, Kahn A, McConnell SK, Berwald-Netter Y, Denoulet P, Chelly J. 1999. Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 23: 247-256.
35. Fujimori K, Takauji R, Tamamaki N. 2002. Differential localization of high- and low-molecular-weight variants of microtubule-associated protein 2 in the developing rat telencephalon. J Comp Neurol 449: 330-342.
36. Gonthier B, Koncina E, Satkauskas S, Perraut M, Roussel G, Aunis D, Kapfhammer JP, Bagnard D. 2009. A PKC-dependent recruitment of MMP-2 controls semaphorin-3A growth-promoting effect in cortical dendrites. PLoS One 4: e5099.
37. Griffith LC. 2004. Regulation of calcium/calmodulin-dependent protein kinase II activation by intramolecular and intermolecular interactions. J Neurosci 24: 8394-8398.
38. Hisaoka T, Morikawa Y, Komori T, Sugiyama T, Kitamura T, Senba E. 2006. Characterization of TROY-expressing cells in the developing and postnatal CNS: the possible role in neuronal and glial cell development. Eur J Neurosci. 23: 3149-3160.
39. Huber G, Matus A. 1984. Differences in the cellular distributions of two microtubule-associated proteins, MAP1 and MAP2, in rat brain. J Neurosci 4: 151-160.
40. 2+/calmodulin-dependent protein kinase II. [Review] Biochem J 364: 593-611.
41. Ichikawa H, Sugimoto T. 2003. Calcium-binding protein-immunoreactive innervation of the rat vibrissa. Brain Res 970: 226-231.
42. Ichikawa H, Sugimoto T. 2005. Peptide 19 in the rat vagal and glossopharyngeal sensory ganglia. Brain Res 1038: 107-112.
43. Ichikawa H, Jacobowitz DM, Sugimoto T. 1992. Calretinin-immunoreactivity in the oro-facial and pharyngeal regions of the rat. Neurosci Lett 146: 155-158.
44. Ichikawa H, Morgan JI, Sugimoto T. 1999. Peptide 19 in the dorsal root ganglion and the mesencephalic trigeminal tract nucleus of the adult rat. Brain Res 821: 231-235.
45. Jiang Z, Belforte JE, Lu Y, Yabe Y, Pickel J, Smith CB, Je HS, Lu B, Nakazawa K. 2010. eIF2alpha phosphorylation-dependent translation in CA1 pyramidal cells impairs hippocampal memory consolidation without affecting general translation. J Neurosci. 30: 2582-2594.
46. Johanson RA, Sarau HM, Foley JJ, Slemmon JR. 2000. Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II in situ. J Neurosci 20: 2860-2866.
47. Johnson LD, Willoughby CA, Burke SH, Paik DS, Jenkins KJ, Tombes RM. 2000. delta Ca(2+)/calmodulin-dependent protein kinase II isozyme-specific induction of neurite outgrowth in P19 embryonal carcinoma cells. J Neurochem 75: 2380-2391.
48. Kahlem P, Sultan M, Herwig R, Steinfath M, Balzereit D, Eppens B, Saran NG, Pletcher MT, South ST, Stetten G, Lehrach H, Reeves RH, Yaspo ML. 2004. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of Down syndrome. Genome Res 14: 1258-1267.
49. Kawasaki H, Crowley JC, Livesey FJ, Katz LC. 2004. Molecular organization of the ferret visual thalamus. J Neurosci 24: 9962-9970.
50. Kim JH, Lee JA, Song YM, Park CH, Hwang SJ, Kim YS, Kaang BK, Son H. 2006. Overexpression of calbindin-D28K in hippocampal progenitor cells increases neuronal differentiation and neurite outgrowth. FASEB J 20: 109-101.
51. Laffaire J, Rivals I, Dauphinot L, Pasteau F, Wehrle R, Larrat B, Vitalis T, Moldrich RX, Rossier J, Sinkus R, Herault Y, Dusart I, Potier MC. 2009. Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development. BMC Genomics 10: 138.
52. Leclerc N, Baas PW, Garner CC, Kosik K. 1996. Juvenile and mature MAP2 isoforms induce distinct patterns of process outgrowth. Mol Biol Cell 7: 443-455.
53. Lomholt JF, Keeling JW, Hansen BF, Ono T, Stoltze K, Kjaer I. 2003. The prenatal development of the human cerebellar field in Down syndrome. Orthod Craniofac Res 6: 220-226.
54. Lyle R, Gehrig C, Neergaard-Henrichsen C, Deutsch S, Antonarakis SE. 2004. Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome. Genome Res 14: 1268-1274.
55. Kip1 lengthens the G1 phase in a mouse model that targets inducible gene expression to central nervous system progenitor cells. Proc Natl Acad Sci U S A 98: 6435-6440.
56. Molyneaux BJ, Arlotta P, Menezes JR, Macklis JD. 2007. Neuronal subtype specification in the cerebral cortex. [Review] Nat Rev Neurosci 8: 427-437.
57. Moody SA, Quigg MS, Frankfurter A. 1989. Development of the peripheral trigeminal system in the chick revealed by an isotype-specific anti-beta-tubulin monoclonal antibody. J Comp Neurol 279: 567-580.
58. Mugnaini E, Berrebi AS, Dahl AL, Morgan JI. 1987. The polypeptide PEP-19 is a marker for Purkinje neurons in cerebellar cortex and cartwheel neurons in the dorsal cochlear nucleus. Arch Ital Biol 126: 41-67.
59. Murray KD, Isackson PJ, Jones EG. 2003. N-methyl-D-aspartate receptor dependent transcriptional regulation of two calcium/calmodulin-dependent protein kinase type II isoforms in rodent cerebral cortex. Neuroscience 122: 407-420.
60. Murray KD, Choudary PV, Jones EG. 2007. Nucleus- and cell-specific gene expression in monkey thalamus. Proc Natl Acad Sci U S A 104: 1989-1994.
61. Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, Parras C, Philpott A, Roberts JM, Guillemot F. 2006. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 20: 1511-1524.
62. Olson LE, Roper RJ, Baxter LL, Carlson EJ, Epstein CJ, Reeves RH. 2004. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev Dyn 230: 581-589.
63. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
64. Plioplys AV. 1987. Down's syndrome. Precocious neurofilament antigen expression. J Neurol Sci 79: 91-100.
65. Przyborski SA, Smith S, Wood A. 2003. Transcriptional profiling of neuronal differentiation by human embryonal carcinoma stem cells in vitro. Stem Cells 21: 459-471.
66. Pulvers JN, Huttner WB. 2009. Brca1 is required for embryonic development of the mouse cerebral cortex to normal size by preventing apoptosis of early neural progenitors. Development. 136: 1859-1868.
67. Putkey JA, Kleerekoper Q, Gaertner TR, Waxham MN. 2003. A new role for IQ motif proteins in regulating calmodulin function. J Biol Chem 278: 49667-49670.
68. Putkey JA, Waxham MN, Gaertner TR, Brewer KJ, Goldsmith M, Kubota Y, Kleerekoper QK. 2008. Acidic/IQ motif regulator of calmodulin. J Biol Chem 283: 1401-1410.
69. Reymond A, Marigo V, Yaylaoglu MB, Leoni A, Ucla C, Scamuffa N, Caccioppoli C, Dermitzakis ET, Lyle R, Banfi S, Eichele G, Antonarakis SE, Ballabio A. 2002. Human chromosome 21 gene expression atlas in the mouse. Nature 420: 582-586.
70. Riederer B, Matus A. 1985. Differential expression of distinct microtubule-associated proteins during brain development. Proc Natl Acad Sci U S A 82: 6006-6009.
71. Rowell JJ, Mallik AK, Dugas-Ford J, Ragsdale CW. 2010. Molecular analysis of neocortical layer structure in the ferret. J Comp Neurol 518: 3272-3289.
72. Sago H, Carlson EJ, Smith DJ, Kilbridge J, Rubin EM, Mobley WC, Epstein CJ, Huang TT. 1998. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci U S A 95: 6256-6261.
73. Sago H, Carlson EJ, Smith DJ, Rubin EM, Crnic LS, Huang TT, Epstein CJ. 2000. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr Res 48: 606-613.
74. Sala A, Scaturro M, Proia P, Schiera G, Balistreri E, Aflalo-Rattenbach R, Creau N, Di Liegro I. 2007. Cloning of a rat-specific long PCP4/PEP19 isoform. Int J Mol Med 19: 501-509.
75. Sangameswaran L, Hempstead J, Morgan JI. 1989. Molecular cloning of a neuron-specific transcript and its regulation during normal and aberrant cerebellar development. Proc Natl Acad Sci U S A 86: 5651-5655.
76. Satgé D, Créau N, Aflalo-Rattenbach R, Ducassou S, Lutz P, Bénard J. 2008. Down syndrome's protection against neuroblastoma the stromal and neural overmaturation tracks. In: Columbus F, editor. Focus on neuroblastoma research. New York: Nova Science Publishers. p 57-100.
77. Schmetsdorf S, Gärtner U, Arendt T. 2007. Constitutive expression of functionally active cyclin-dependent kinases and their binding partners suggests noncanonical functions of cell cycle regulators in differentiated neurons. Cereb Cortex 17: 1821-1829.
78. Schwaller B, Br̈ckner G, Celio MR, Härtig W. 1999. A polyclonal goat antiserum against the calcium-binding protein calretinin is a versatile tool for various immunochemical techniques. J Neurosci Methods 92: 137-144.
79. Siarey RJ, Villar AJ, Epstein CJ, Galdzicki Z. 2005. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome. Neuropharmacology 49: 122-128.
80. Siarey RJ, Kline-Burgess A, Cho M, Balbo A, Best TK, Harashima C, Klann E, Galdzicki Z. 2006. Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome. J Neurochem 98: 1266-1277. Erratum in: J Neurochem 2006, 99:1320.
81. Slemmon JR, Morgan JI, Fullerton SM, Danho W, Hilbush BS, Wengenack TM. 1996. Camstatins are peptide antagonists of calmodulin based upon a conserved structural motif in PEP-19, neurogranin, and neuromodulin. J Biol Chem 271: 15911-15917.
82. Thomas S, Thiery E, Aflalo R, Vayssettes C, Verney C, Berthuy I, Créau N. 2003. PCP4 is expressed in ectoderm and neurectoderm derivatives during mouse embryogenesis. Gene Expr Patterns 3: 93-97.
83. Thomas S, Aflalo-Rattenbach R, Mouton-Liger F, Créau N. 2005. PCP4 (PEP-19): function, regulation and neurodegenerative diseases. In: di Liegro I, Savettieri G, editors. Molecular Bases of Neurodegeneration. Kerala, India: Research Signpost Publisher. p 199-212.
84. Thullberg M, Bartkova J, Khan S, Hansen K, Rönnstrand L, Lukas J, Strauss M, Bartek J. 2000. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors. FEBS Lett 470: 161-166.
85. Tombes RM, Faison MO, Turbeville JM. 2003. Organization and evolution of multifunctional Ca(2+)/CaM-dependent protein kinase genes. Gene 322: 17-31.
86. Utal AK, Stopka AL, Roy M, Coleman PD. 1998. PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease. Neuroscience 86: 1055-1063.
87. Wang Z, Engler P, Longacre A, Storb U. 2001. An efficient method for high-fidelity BAC/PAC retrofitting with a selectable marker for mammalian cell transfection. Genome Res 11: 137-142.
88. Winsky L, Kuźnicki J. 1995. Distribution of calretinin, calbindin D28k, and parvalbumin in subcellular fractions of rat cerebellum: effects of calcium. J Neurochem 65: 381-388.
89. Winter TC, Ostrovsky AA, Komarniski CA, Uhrich SB. 2000. Cerebellar and frontal lobe hypoplasia in fetuses with trisomy 21: usefulness as combined US markers. Radiology 214: 533-538.
90. Ziai R, Pan YC, Hulmes JD, Sangameswaran L, Morgan JI. 1986. Isolation, sequence, and developmental profile of a brain-specific polypeptide, PEP-19. Proc Natl Acad Sci USA 83: 8420-8423.
91. Ziai MR, Sangameswaran L, Hempstead JL, Danho W, Morgan JI. 1988. An immunochemical analysis of the distribution of a brain-specific polypeptide, PEP-19. J Neurochem 51: 1771-1776.
92. Zindy F, Soares H, Herzog KH, Morgan J, Sherr CJ, Roussel MF. 1997. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Cell Growth Differ 8: 1139-1150.
93. Zindy F, Cunningham JJ, Sherr CJ, Jogal S, Smeyne RJ, Roussel MF. 1999. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proc Natl Acad Sci U S A 96: 13462-13467.